Platinum analogs as potential new drugs for bladder cancer = Les analogues du platine, nouvelles drogues potentielles dans le cancer de la vessieCREAVEN, P. J.Urology (Ridgewood, NJ). 1984, Vol 23, Num 3, pp 54-60, issn 0090-4295, supplArticle

Cytotoxic chemotherapeutic agents under development with a possible future role in prostate cancerCREAVEN, P. J.The Prostate. 1984, Vol 5, Num 5, pp 485-493, issn 0270-4137Article

In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatinPENDYALA, L; CREAVEN, P. J.Cancer research (Baltimore). 1993, Vol 53, Num 24, pp 5970-5976, issn 0008-5472Article

Phase I study of paclitaxel and carboplatin : implications for trials in head and neck cancerCREAVEN, P; RAGHAVAN, D; LAKSHMI PENDYALA et al.Seminars in oncology. 1995, Vol 22, Num 5, pp 13-16, issn 0093-7754, SUP12Conference Paper

A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancerO'CONNOR, T; RUSTUM, Y; LEVINE, E et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 1, pp 125-131, issn 0344-5704, 7 p.Article

Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinomaPETRELLI, N. J; RODRIGUEZ-BIGAS, M; RUSTUM, Y et al.Cancer. 1993, Vol 72, Num 5, pp 1543-1546, issn 0008-543XArticle

Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone cancer and leukemia group B trial 8171BUDMAN, D. R; ANDERSON, J; OBRECHT, J. P et al.Cancer treatment reports. 1985, Vol 69, Num 6, pp 719-722, issn 0361-5960Article

The clinical development of paclitaxel and the paclitaxel/carboplatin combinationSCHWARTZ, G. N; PENDYALA, L; KINDLER, H et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1543-1548, issn 0959-8049Conference Paper

A combination of 5-fluorouracil and thymidine in advanced colorectal carcinomaSTERNBERG, A; PETRELLI, N. J; AV, J et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 3, pp 218-222, issn 0344-5704Article

Effect of renal function impairment on iproplatin pharmacokinetics and relation to toxicityLAKSHMI PENDYALA; MADAJEWICZ, S; CREAVEN, P. J et al.Cancer research (Baltimore). 1985, Vol 45, Num 11, pp 5936-5938, issn 0008-5472Article

Response to tumor necrosis factor in two cases of psoriasisCREAVEN, P. J; STOLL, H. L.Journal of the American Academy of Dermatology. 1991, Vol 24, Num 5, pp 735-737, issn 0190-9622, 3 p., p.1Article

Clinical pharmacokinetics of 3-deazaguaninePENDYALA, L; CREAVEN, P. J; WHITFIELD, L. R et al.Cancer chemotherapy and pharmacology. 1991, Vol 29, Num 1, pp 33-36, issn 0344-5704Article

Carboplatin for small cell lung cancer : progress toward greater efficacy and reduced toxicityRAGHAVAN, D; PEREZ, R; CREAVEN, P et al.Seminars in oncology. 1994, Vol 21, Num 3, pp 1-8, issn 0093-7754, SUP6Conference Paper

A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinomaPALMERI, S; GEBBIA, V; RUSSO, A et al.Journal of chemotherapy. 1991, Vol 3, Num 3, pp 170-175, issn 1120-009X, 6 p.Article

Modulation of 1-β-D-arabinofuranosylcytosine metabolism by thymidine in human acute leukemiaZITTOUN, R; ZITTOUN, J; MARQUET, J et al.Cancer research (Baltimore). 1985, Vol 45, Num 10, pp 5186-5192, issn 0008-5472Article

Pharmacokinetics and metabolism of nilutamideCREAVEN, P. J; LAKSHMI PENDYALA; TREMBLAY, D et al.Urology (Ridgewood, NJ). 1991, Vol 37, Num 2, pp 13-19, issn 0090-4295, 7 p., SUPConference Paper

Phase II trial of continuous-infusion iproplatin (CHIP) and 5-fluorouracil (5-FU) in advanced colorectal carcinomaPETRELLI, N. J; CREAVEN, P. J; HERRERA, L et al.Cancer chemotherapy and pharmacology. 1989, Vol 23, Num 1, pp 61-62, issn 0344-5704Article

Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorinMEROPOL, N. J; BLUMENSON, L. E; CREAVEN, P. J et al.American journal of clinical oncology. 1998, Vol 21, Num 2, pp 135-138, issn 0277-3732Article

PHASE I STUDY OF HIGH-DOSE METHOTREXATE WITH THYMIDINE AND LOW-DOSE LEUCOVORINBRUNO S; GRINDEY G; ZAKRZEWSKI S et al.1982; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 11; PP. 4824-4826; BIBL. 19 REF.Article

Intracellular glutathione and cytotoxicity of platinum complexesPENDYALA, L; CREAVEN, P. J; PEREZ, R et al.Cancer chemotherapy and pharmacology. 1995, Vol 36, Num 4, pp 271-278, issn 0344-5704Article

Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomersPENDYALA, L; KIDANI, Y; PEREZ, R et al.Cancer letters. 1995, Vol 97, Num 2, pp 177-184, issn 0304-3835Article

DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum(II)PENDYALA, L; ARAKALI, A. V; SANSONE, P et al.Cancer chemotherapy and pharmacology. 1990, Vol 27, Num 3, pp 248-250, issn 0344-5704, 3 p.Article

Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin : A potential role for growth factor as mucosal protectantMEROPOL, N. J; RUSTUM, Y. M; CREAVEN, P. J et al.Cancer investigation. 1999, Vol 17, Num 1, pp 1-9, issn 0735-7907Article

Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell linePENDYALA, L; PEREZ, R; WEINSTEIN, A et al.Cancer chemotherapy and pharmacology. 1997, Vol 40, Num 1, pp 38-44, issn 0344-5704Article

Page / 3